| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 13, 2024 | Dec 13, 2024 | Niagen Bioscience, Inc. | Director | Sell | 22.5 | -37,161 | -1.58% | ✗ | $230K |
| Jun 12, 2023 | Jun 13, 2023 | Niagen Bioscience, Inc. | Director | Buy | 61.3 | +7,000 | 0.30% | ✗ | $11.8K |
| Dec 10, 2020 | Dec 11, 2020 | Niagen Bioscience, Inc. | Chair | Sell | 22.5 | -37,829 | -14.43% | ✗ | $196.3K |
| Mar 11, 2019 | Mar 12, 2019 | Niagen Bioscience, Inc. | Chair | Sell | 32.5 | -14,390 | -0.62% | ✗ | $50.4K |
| May 15, 2018 | May 16, 2018 | Niagen Bioscience, Inc. | CEO | Buy | 61.3 | +9,800 | 0.43% | ✗ | $35.2K |
| Mar 29, 2018 | Apr 2, 2018 | Niagen Bioscience, Inc. | CEO | Sell | 58.8 | -474 | -0.02% | ✓ | $2.2K |
| Mar 27, 2018 | Mar 29, 2018 | Niagen Bioscience, Inc. | CEO | Sell | 45.0 | -24,578 | -1.07% | ✓ | $113.1K |
| Jan 10, 2018 | Jan 12, 2018 | Niagen Bioscience, Inc. | CEO | Sell | 45.0 | -28,379 | -1.13% | ✓ | $184.9K |
| Dec 21, 2017 | Dec 26, 2017 | Niagen Bioscience, Inc. | CEO | Sell | 38.8 | -58,400 | -2.50% | ✓ | $361.5K |
| Dec 12, 2016 | Dec 12, 2016 | Niagen Bioscience, Inc. | CEO | Buy | 55.0 | +2,000 | 0.09% | ✗ | $4.8K |
| Sep 1, 2016 | Sep 2, 2016 | Niagen Bioscience, Inc. | CEO | Buy | 55.0 | +1,500 | 0.07% | ✗ | $5K |
| Aug 22, 2014 | Aug 22, 2014 | Niagen Bioscience, Inc. | CEO | Buy | 55.0 | +5,000 | 0.06% | ✗ | $5.8K |
| Jun 13, 2012 | Jun 15, 2012 | Niagen Bioscience, Inc. | CEO | Buy | 55.0 | +5,000 | 0.06% | ✗ | $3.6K |
| May 16, 2012 | May 17, 2012 | Niagen Bioscience, Inc. | CSO | Buy | 55.0 | +5,000 | 0.06% | ✗ | $2.7K |
| Feb 10, 2012 | Feb 14, 2012 | Niagen Bioscience, Inc. | CSO | Buy | 68.8 | +66,665 | 0.87% | ✗ | $50K |
| Dec 7, 2011 | Dec 8, 2011 | Niagen Bioscience, Inc. | CEO | Buy | 55.0 | +7,500 | 0.10% | ✗ | $4.5K |
| Dec 8, 2010 | Dec 15, 2010 | Niagen Bioscience, Inc. | CEO | Buy | 55.0 | +5,000 | 0.07% | ✗ | $7.5K |